India’s vaccination drive has been reliant on two ‘Made In India’ vaccines, which are Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. While SII’s Covishield is developed by Oxford AstraZeneca, Bharat Biotech’s Covaxin has been developed indigenously and has been India’s success story in the vaccination drive so far.
Since the Indian government granted approvals to Covaxin, a number of media houses, media persons and politicians have been busy peddling blatant falsehoods and misinformation against the indigenously developed vaccine that has proven its efficacy and is now approved by the WHO too.
Recently, Bharat Biotech had shared a list of recent media reports from Indian media outlets that have spread misinformation, and sometimes blatant lies to create confusion regarding the vaccine. The company ‘fact-checked’ those lies one by one.
Bharat Biotech listed an article by Money Control dated 29 December 2021 that claimed Bharat Biotech’s ability to provide vaccine doses for 10 crore Indians in the 15-18 age group is doubtful.
Bharat Biotech stated that they have provided crores of doses in the last 11 months of the vaccination campaign and the vaccination drive for the 15-18 age group will also be carried out through several months.
Another statement in the article claimed that they had a ‘botched up’ attempt to revive the Haskins Veterinary Institute in Gujarat and their tech transfer efforts so far have...
Why it Matters Federal research agencies face mounting pressure to prevent fraud in grant-making, and Congress is moving to hold them accountable. A House subcommittee grant fraud hearing schedule...